StockWatch
·

AAREY DRUGS & PHARMACEUTICALS LTD. Q4 FY25 Results

AAREYDRUGSQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue108.1019.2%
Total Income115.6414.0%
Expenditure114.0114.3%
PBT1.6316.1%
Net Profit0.4734.5%
OPM-4.49%3.92pp
NPM0.41%0.12pp
EPS0.0292.3%
View full financials

Informational and educational content only. Not investment advice.